# LZTR1 Loss Reduces Vimentin Expression and Motility in Hep3B Hepatocellular Carcinoma Cells

**Authors:** Gökhan Yıldız, Soner Karabulut, Umit Uzun, Onur Obut, Vahap Eldem, Tuba Dinçer, Bayram Toraman

PMC · DOI: 10.3390/ijms27041866 · International Journal of Molecular Sciences · 2026-02-15

## TL;DR

This study shows that losing the LZTR1 gene in liver cancer cells reduces vimentin and cell movement, suggesting LZTR1 plays a role in cancer cell behavior.

## Contribution

The study identifies LZTR1 as a regulator of epithelial-mesenchymal plasticity and motility in hepatocellular carcinoma cells.

## Key findings

- LZTR1 loss suppresses vimentin expression at both transcript and protein levels.
- LZTR1 deficiency impairs wound closure and reduces migration and invasion in Hep3B cells.
- LZTR1 KO cells show a hybrid epithelial-mesenchymal pattern linked to epithelial-mesenchymal plasticity.

## Abstract

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, underscoring the need to elucidate molecular mechanisms that regulate tumor cell state and behavior. Leucine zipper–like post-translational regulator 1 (LZTR1) regulates RAS/mitogen-activated protein kinase (MAPK) signaling, yet LZTR1-dependent transcriptional alterations in HCC cells remain poorly defined. To address this gap and determine how LZTR1 loss reshapes signaling, transcriptional programs, and cellular phenotypes, we established a LZTR1 knockout (KO) Hep3B model and combined pathway profiling with transcriptomic and functional analyses. Immunoblotting revealed increased phosphorylation across the RAF–MEK–ERK–RSK cascade in LZTR1 KO cells. Transcriptome-wide RNA sequencing (RNA-Seq) identified differentially expressed genes, and selected findings were validated by qRT-PCR. Gene set enrichment analysis indicated that the epithelial–mesenchymal transition (EMT) gene set was enriched in control cells. At the protein level, LZTR1 loss remodeled EMT-associated markers in a hybrid epithelial–mesenchymal pattern consistent with epithelial–mesenchymal plasticity (EMP). Vimentin was suppressed at transcript and protein levels. Functionally, LZTR1 KO cells exhibited impaired wound closure and reduced transwell migration and invasion. Collectively, these findings define an EMP-related molecular and phenotypic state associated with LZTR1 deficiency in Hep3B cells, providing insight into how LZTR1 loss reshapes tumor cell behavior in HCC.

## Linked entities

- **Genes:** LZTR1 (leucine zipper like post translational regulator 1) [NCBI Gene 8216], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446]
- **Proteins:** PRELID1 (PRELI domain containing 1)
- **Diseases:** hepatocellular carcinoma (MONDO:0007256), HCC (MONDO:0007256)

## Full-text entities

- **Genes:** MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, CDH11 (cadherin 11) [NCBI Gene 1009] {aka CAD11, CDHOB, ESWS, OB, OSF-4, TBHS2}, KLHL2 (kelch like family member 2) [NCBI Gene 11275] {aka ABP-KELCH, MAV, MAYVEN}, GALNT6 (polypeptide N-acetylgalactosaminyltransferase 6) [NCBI Gene 11226] {aka GALNAC-T6, GalNAcT6}, POF1B (POF1B actin binding protein) [NCBI Gene 79983] {aka POF, POF2B}, ZEB1 (zinc finger E-box binding homeobox 1) [NCBI Gene 6935] {aka AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, GATA5 (GATA binding protein 5) [NCBI Gene 140628] {aka CHTD5, GATAS, bB379O24.1}, CUL3 (cullin 3) [NCBI Gene 8452] {aka CUL-3, NEDAUS, PHA2E}, TRIB2 (tribbles pseudokinase 2) [NCBI Gene 28951] {aka C5FW, GS3955, TRB2}, NPNT (nephronectin) [NCBI Gene 255743] {aka EGFL6L, POEM}, RPS6KA2 (ribosomal protein S6 kinase A2) [NCBI Gene 6196] {aka HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}, RIT1 (Ras like without CAAX 1) [NCBI Gene 6016] {aka NS8, RIBB, RIT, ROC1}, DUSP5 (dual specificity phosphatase 5) [NCBI Gene 1847] {aka DUSP, HVH3}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, ETS1 (ETS proto-oncogene 1, transcription factor) [NCBI Gene 2113] {aka ETS-1, EWSR2, c-ets-1, p54}, MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase) [NCBI Gene 10296] {aka EMLP, EMP, GID9, HLC-10, P44EMLP, PIG5}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, RAF1 (Raf-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5894] {aka CMD1NN, CRAF, NS5, Raf-1, c-Raf}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, NRAS (NRAS proto-oncogene, GTPase) [NCBI Gene 4893] {aka ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6}, BMP7 (bone morphogenetic protein 7) [NCBI Gene 655] {aka OP-1}, HOXB-AS3 (HOXB cluster antisense RNA 3) [NCBI Gene 404266], ACTG1 (actin gamma 1) [NCBI Gene 71] {aka ACT, ACTG, DFNA20, DFNA26, HEL-176}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, RELN (reelin) [NCBI Gene 5649] {aka ETL7, LIS2, PRO1598, RL}, AMOTL1 (angiomotin like 1) [NCBI Gene 154810] {aka CFCHS, JEAP}, VIM (vimentin) [NCBI Gene 7431], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CAT (catalase) [NCBI Gene 847], TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, LZTR1 (leucine zipper like post translational regulator 1) [NCBI Gene 8216] {aka BTBD29, LZTR-1, NS10, NS2, SWNTS2}, CLDN1 (claudin 1) [NCBI Gene 9076] {aka CLD1, ILVASC, SEMP1}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}
- **Diseases:** leukemia (MESH:D007938), tumorigenic (MESH:D002471), acral melanoma (MESH:D008545), schwannomatosis (MESH:C536641), lung adenocarcinoma (MESH:D000077192), injury to (MESH:D014947), Noonan syndrome-associated cardiomyopathy (MESH:D009634), epithelial malignancies (MESH:D002277), liver tumor (MESH:D008113), glioblastoma (MESH:D005909), Tumor (MESH:D009369), Hepatocellular Carcinoma (MESH:D006528)
- **Chemicals:** sodium fluoride (MESH:D012969), glycerol (MESH:D005990), puromycin (MESH:D011691), penicillin (MESH:D010406), mitomycin C (MESH:D016685), Alexa Fluor-647 (MESH:C569686), Phalloidin (MESH:D010590), Agarose (MESH:D012685), PFA (MESH:C003043), sodium pyrophosphate (MESH:C003319), CO2 (MESH:D002245), crystal violet (MESH:D005840), BCA (MESH:C047117), NaCl (MESH:D012965), L-glutamine (MESH:D005973), MgCl2 (MESH:D015636), E2311 (-), NaHCO3 (MESH:D017693), water (MESH:D014867), streptomycin (MESH:D013307), Alexa Fluor 488 (MESH:C000711379), Triton X-100 (MESH:D017830), DMSO (MESH:D004121), EDTA (MESH:D004492), acetic acid (MESH:D019342), SDS (MESH:D012967), bromophenol blue (MESH:D001978), amino acids (MESH:D000596), TBS-T (MESH:C027647), Tween-20 (MESH:D011136), Oligonucleotides (MESH:D009841)
- **Species:** Homo sapiens (human, species) [taxon 9606], Hepatitis B virus (no rank) [taxon 10407]
- **Mutations:** p.His51Leufs*18, c.154_176del, g.20982525_20982547del, g.20982251_20982549delinsACTG, c.-114_184delinsACTG
- **Cell lines:** PX462 — Homo sapiens (Human), Hybrid cell line (CVCL_ZR66), P36935 — Atilax paludinosus (Marsh mongoose), Finite cell line (CVCL_6365), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), LSKO-104 — Mus musculus (Mouse), Hybridoma (CVCL_B3QI), Hep3B — Homo sapiens (Human), Childhood hepatocellular carcinoma, Cancer cell line (CVCL_0326), NM_006767.4 — Bos taurus (Bovine), Finite cell line (CVCL_3074), SC-12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_UR38)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940621/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940621/full.md

## References

85 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940621/full.md

---
Source: https://tomesphere.com/paper/PMC12940621